This text is a result of machine translation.
Shanghai to Launch Its First Direct Passenger Flight Route to a Central Asian Country in May
Anjoy Foods Q3 Net Profit Totaled CNY 386 million, with an Impressive YoY Increase of 63.75%
Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum
A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.
May 18, 2026 02:22 PM
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
China's Outbound Non-financial Direct Investment Increased 18.8% YoY
Robust medical: it plans to acquire the controlling equity of Hunan Ping An medical equipment
Mask protection unit rose in the afternoon
LLVision Showcases End-to-End AR+AI Deployment Capabilities at WAIC as AI Moves into Real-World Business
As artificial intelligence shifts from competing on model capabilities to delivering real-world business value, AR+AI is emerging as a key interface connecting digital intelligence with physical environments.
Updated 7 hours ago
Insilico Medicine (英矽智能) Signs Strategic Drug Discovery Partnership with Takeda (武田制药), Deal Worth Up to US$600 Million
Chinese AI drug discovery company Insilico Medicine (英矽智能) has signed a global strategic collaboration with Japanese pharmaceutical company Takeda (武田制药), with the total potential deal value reaching up to US$600 million. Announced in early July, the agreement marks another milestone in the international commercialization of China's AI-powered drug discovery technologies through collaboration with a leading multinational pharmaceutical company.
Jul 16, 2026 02:33 PM
Imber: the shareholder Ruan bin has completed the reduction of 337500 shares and plans to continue to reduce no more than 1.32% of the shares
Robust medical: by the end of October, 1159400 shares had been repurchased
Alibaba's Qwen to Power Apple Intelligence in China, Bringing a Chinese Foundation Model into Apple's AI Ecosystem
Alibaba Group (阿里巴巴)'s large language model Qwen (通义千问) will provide core AI capabilities for Apple Intelligence in mainland China, following regulatory approval for Apple's AI services in the country.
Jul 16, 2026 02:28 PM
China’s AI-Linked Computing Trade Reaches CNY 5.13 Trillion as June Exports Surge
China’s exports rose 27% year on year in U.S.-dollar terms in June, the fastest pace in four months, as global demand for artificial intelligence-related hardware provided a fresh source of support for the country’s export sector.
Jul 15, 2026 11:13 AM
Robust medical treatment: affected by the recent spread of delta virus strain, the company's demand for protective products such as masks and protective clothing has increased significantly
Xinxiang Chemical Fiber: some production workshops of viscose filament are temporarily shut down due to water inflow
EqualOcean Releases 2026 Chinese GoGlobal Physical Retail Brands Top 10 at GGF2026
Jun 17, 2026 02:50 PM
EqualOcean Releases 2026 Chinese GoGlobal HealthTech Brands Top 10 at GGF2026
Jun 17, 2026 02:48 PM